Introduction: Schizophrenia is a chronic mental disorder, and treatment is based on the use
of antipsychotics, such as clozapine. These drugs have been associated with obesity and …

Background: Both obesity and smoking are common in schizophrenia patients taking
clozapine, causing cardiovascular disease and premature deaths. Methods: Two hundred …

Over the last three decades, an epidemic of obesity has markedly affected patients suffering
from mental illnesses such as schizophrenia. Antipsychotic medications used to treat …

Increase in body weight was observed in more than 50% of schizophrenic patients who
receive antipsychotic drugs in general. 8 Body mass index (BMI) is significantly higher in …

The prevalence of obesity in inpatients of a German psychiatric rehabilitation center for
adolescents and young adults (mean age 19.5 years) is assessed and set into relationship …

Objective Clozapine is the first choice in drug-resistant schizophrenia but also causes
important weight changes. This might discourage clinicians who are concerned about the …

Obesity is a highly prevalent illness in schizophrenia patients. This review evaluates recent
literature on the relationship between obesity risk and schizophrenia psychopathology. Ten …

Objective: Patients with schizophrenia and schizoaffective disorder suffer from increased
rates of weight gain that might lead to severe medical problems. This study aimed to …

Most patients with schizophrenia regularly used medications and it is difficult to disengage
metabolic abnormalities which are related to disease, from those that may have been …

Objective: The presence of obesity and increases in body mass are important risk factors for
cardiovascular disease and diabetes. This study examined the effects of olanzapine …